Adverum Biotechnologies's total assets for Q3 2024 were $234.38M, a decrease of -7.65% from the previous quarter. ADVM total liabilities were $90.26M for the fiscal quarter, a 5.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.